Canadian scientist Mark Wainberg—described as a "giant" of HIV science and who had recently been working on finding a cure for the condition—has died at the age of 71, UNAIDS said on Thursday.
Apr 13, 2017
0
0
New research published online first in the Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy nearly a decade ago.
Jul 22, 2012
0
0
Investigating the genetic footprint that drug resistance causes in HIV, researchers in Europe have discovered that compensatory polymorphisms enable resistant viruses to survive. Presented in the journal Retrovirology, the ...
Oct 26, 2012
0
0
With antibiotic resistance on the rise, scientists are looking for innovative ways to combat bacterial infections. The pathogen that causes conditions from strep throat to flesh-eating disease is among them, but scientists ...
Feb 25, 2015
0
6
Former South African president Nelson Mandela once emphasized that the war against AIDS could not be won without confronting the country's tuberculosis epidemic. For the last 16 years, a group of Yale researchers in the Yale ...
Aug 28, 2018
0
2
New computer models described today in the Journal of Antimicrobial Chemotherapy predict how patients whose HIV therapy is failing will respond to any new combination of drugs, without the need for an HIV genotype: a test ...
Nov 26, 2013
0
0
Among women who acquired HIV during ASPIRE, researchers found no differences in the frequency and patterns of HIV drug resistance between those assigned to use the ring containing an anti-retroviral (ARV) drug called dapivirine ...
Oct 18, 2016
0
0
The newly appointed deputy chief of the United Nations HIV-fighting program, Brazilian Luiz Loures, hailed his own country's achievements in the fight against the deadly global epidemic in an interview published Saturday.
Dec 22, 2012
0
0
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL and funded by Wellcome.
Nov 30, 2016
0
0
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two ...
Jul 23, 2012
0
0
